Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Duality Biotherapeutics, Inc. ( (HK:9606) ) is now available.
Duality Biotherapeutics, Inc. has announced its upcoming Annual General Meeting (AGM) scheduled for June 20, 2025, in Shanghai, China. The meeting will address several key resolutions, including the adoption of the company’s audited financial statements for 2024, the re-election of directors, and the re-appointment of auditors. Additionally, the company seeks approval for the repurchase of shares and the issuance of additional shares, which could impact its market operations and shareholder value.
The most recent analyst rating on (HK:9606) stock is a Buy with a HK$268.30 price target. To see the full list of analyst forecasts on Duality Biotherapeutics, Inc. stock, see the HK:9606 Stock Forecast page.
More about Duality Biotherapeutics, Inc.
Duality Biotherapeutics, Inc. operates in the biotherapeutics industry, focusing on the development and commercialization of innovative therapeutic solutions. The company is incorporated in the Cayman Islands and is listed on the Stock Exchange of Hong Kong.
Average Trading Volume: 945,590
See more data about 9606 stock on TipRanks’ Stock Analysis page.